share_log

VistaGen Therapeutics | 8-K: Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update

SEC ·  Nov 7, 2024 22:38
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.